Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
CALL
Ascendis Pharma A/S
ASND
$16.8B
| $3.25M | ﹤0.01% |
35,000
-15,000
| -30% | -$1.41M |
|
3177
Casey's General Stores
CASY
$31.6B
| $3.25M | ﹤0.01% |
17,567
+3,133
| +22% | +$630K |
|
|
DFTX
3178
Definium Therapeutics
DFTX
$5.99B
| $3.25M | ﹤0.01% |
338,341
+309,252
| +1,063% | +$3.91M |
|
3179
RELX
RELX
$62.1B
| $3.23M | ﹤0.01% |
119,960
-424,139
| -78% | -$12.2M |
|
|
LBPH
3180
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $3.22M | ﹤0.01% |
1,043,216
-2,713
| -0.3% | -$12.5K |
|
|
SPCMU
3181
DELISTED
Sound Point Acquisition Corp I, Ltd Unit
SPCMU
| $3.22M | ﹤0.01% |
320,000
-300,000
| -48% | -$3.03M |
|
3182
Arcturus Therapeutics
ARCT
$200M
| $3.22M | ﹤0.01% |
+204,596
| New | +$4.01M |
|
3183
PUT
Best Buy
BBY
$17.4B
| $3.22M | ﹤0.01% |
49,400
-472,600
| -91% | -$39.4M |
|
3184
Cytokinetics
CYTK
$10.8B
| $3.21M | ﹤0.01% |
81,742
+68,637
| +524% | +$2.76M |
|
3185
PROG Holdings
PRG
$1.68B
| $3.21M | ﹤0.01% |
194,581
-574,874
| -75% | -$14.7M |
|
3186
C4 Therapeutics
CCCC
$400M
| $3.21M | ﹤0.01% |
425,647
-565,294
| -57% | -$4.97M |
|
3187
PUT
Privia Health
PRVA
$2.86B
| $3.2M | ﹤0.01% |
+110,000
| New | +$2.8M |
|
|
NESRW
3188
CALL
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
| $3.2M | ﹤0.01% |
9,700,200
+1,200
| +0% | +$615 |
|
3189
PUT
DuPont de Nemours
DD
$19.1B
| $3.2M | ﹤0.01% |
45,888
+14,021
| +44% | +$1.15M |
|
3190
CALL
Gold Fields
GFI
$36.8B
| $3.19M | ﹤0.01% |
+350,000
| New | +$4.18M |
|
|
LAZR
3191
DELISTED
Luminar Technologies
LAZR
| $3.19M | ﹤0.01% |
35,879
-52,494
| -59% | -$8.39M |
|
3192
Oportun Financial
OPRT
$356M
| $3.18M | ﹤0.01% |
384,076
+192,209
| +100% | +$2.22M |
|
|
ASAQ
3193
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
| $3.17M | ﹤0.01% |
319,790
-719
| -0.2% | -$7.11K |
|
3194
PUT
AbCellera Biologics
ABCL
$2.85B
| $3.17M | ﹤0.01% |
+297,200
| New | +$2.52M |
|
3195
Bilibili
BILI
$7.95B
| $3.16M | ﹤0.01% |
123,597
-553,167
| -82% | -$13.3M |
|
3196
First Bancorp
FBP
$4.42B
| $3.16M | ﹤0.01% |
245,108
-928,904
| -79% | -$12.7M |
|
|
NESR
3197
National Energy Services Reunited Corp
NESR
$3.61B
| $3.16M | ﹤0.01% |
466,566
+75,131
| +19% | +$547K |
|
3198
CALL
Idexx Laboratories
IDXX
$46.9B
| $3.16M | ﹤0.01% |
+9,000
| New | +$3.67M |
|
3199
CALL
Nucor
NUE
$62.5B
| $3.15M | ﹤0.01% |
30,200
-48,800
| -62% | -$6.6M |
|
3200
Newmark Group
NMRK
$2.52B
| $3.15M | ﹤0.01% |
325,796
+309,018
| +1,842% | +$3.58M |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.